SGLT2 inhibitors for treatment of Type 2 diabetes mellitus: Focus on Canagliflozin
The incidence of type 2 diabetes mellitus (T2DM) is increasing worldwide. The existing therapeutic classes of antidiabetic drugs are not adequately effective in maintaining long-term glycemic control in most patients, even when used in combination. Many marketed compounds do not address relevant asp...
Shranjeno v:
Main Authors: | , |
---|---|
Format: | Knjiga |
Izdano: |
Wolters Kluwer Medknow Publications,
2014-01-01T00:00:00Z.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Kopija 1 | Prosto |